A Food and Drug Administration analysis shows a drop in heart attacks and strokes among people taking Vytorin in the early stages of chronic kidney disease, before they need dialysis.
Read More...
Read the complete post at http://www.npr.org/blogs/health/2011/10/31/141880804/controversial-cholesterol-pill-vytorin-shows-promise-for-kidney-patients?ft=1&f=103537970
Posted
Oct 31 2011, 03:29 PM
by
Shots - Health Blog